Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens

Biorheology

Volumn 41, Issue 3-4, 2004, Pages 469-476

  Angoulvant, D ^a   Clerc, A ^b   Benchalal, S ^b   Galambrunc, C ^c   Farre, A ^b   Bertrand, Y ^c   Eljaafari, Assia ^a,b,d  

^a UNIVERSITÉ LYON 1   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c HÔPITAL DEBROUSSE   (France)

^d CHU NANCY BRABOIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CHROMIUM; HLA ANTIGEN CLASS 1; PHYTOHEMAGGLUTININ; RECOMBINANT INTERLEUKIN 2;

ANTIGEN EXPRESSION; BLAST CELL; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; LYMPHOCYTE DIFFERENTIATION; MESENCHYME CELL; MIXED LYMPHOCYTE REACTION; STEM CELL; SUPERNATANT; T LYMPHOCYTE ACTIVATION;

CELL DIFFERENTIATION; CELL LINE, TUMOR; CELLS, CULTURED; HUMANS; INTERLEUKIN-2; ISOANTIGENS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE CULTURE TEST, MIXED; MESODERM; STEM CELLS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 4644232573     PISSN: 0006355X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. A. Bartholomew, C. Sturgeon, M. Siatskas, K. Ferrer, K. McIntosh, S. Patil, W. Hardy, S. Devine, D. Ucker, R. Deans, A, Moseley and R. Hoffman, Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo, Exp. Hematol. 30 (2002), 42-48.
2. R.J. Deans and A.B. Moseley, Mesenchymal stem cells: Biology and potential clinical uses: review, 28 (2000), 875-884.
3. S.M. Devine and R. Hoffman, Role of mesenchymal stem cells in hematopoietic stem cell transplantation. Review, Curr. Opin. Hematol. 7 (2000), 358-363.
4. M. Di Nicola, C. Carlo-Stella, M. Magni, M. Milanesi, P.D. Longoni, P. Matteucci, S. Grisanti and A.M. Gianni, Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli, Blood 99 (2002), 3838-3843.
5. G. Ferrari, G. Cusella-De Angelis and M. Colletta et al., Muscle regeneration by bone marrow-derived myogenic progenitors, 279 (1998), 1528-1530.
6. A. Fridenstein, Stromal bone marrow cells and the hematopietic microenvironment, Arkh. Pathol. 44 (1982), 3-11.
7. K. Fukuda, Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering, Artif. Organs 25 (2001), 187-193.
8. M.C. Galmiche, V.E. Koteliansky, J. Briere, P. Herve and P. Charbord, Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway, Blood 82 (1993), 66-76.
9. S. Gronthos and P.J. Simmons, The bioloy and application of human bone marrow stromal cell precursors, J. Hematother, 5 (1995), 15-23.
10. H.W. Hirte, D.A. Clark, G. O'Connell, J. Rusthoven and J. Mazurka, Reversal of suppression of lymphokine-activated killer cells by transforming growth factor-beta in ovarian carcinoma ascitic fluid requires interleukin-2 combined with anti-CD3 antibody, Cell. Immunol. 142 (1992), 207-216.
11. E.M. Horwitz, P.L. Gordon, W.K. Koo, J.C. Marx, M.D. Neel, R.Y. McNall, L. Muul and T. Hofmann, Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone, Proc. Natl. Acad. Sci. USA 99 (2002), 8932-8937.
12. E.M. Horwitz, D.J. Prockop, L.A. Fitzpatrick, W.W. Koo, P.L. Gordon, M. Neel, M. Sussman, P. Orchard, J.C. Marx, R.E. Pyeritz and M.K. Brenner, Nat. Med. 5 (1999), 309-313.
13. M. Krampera, S. Glennie, J. Dyson, D. Scott, R. Laylor, E. Simpson and F. Dazzi, Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide, Blood 101 (2003), 3722-3729.
14. R.F. Pereira, K.W. Halford, M.D. O'Hara, D.B. Leeper, B.P. Sokolov, M.D. Pollard, O. Bagasra and D.J. Prockop, Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice, Proc. Natl. Acad. Sci. USA 92 (1995), 4857-4861
15. M.F. Pittenger, A.M. Mackay, S.C. Beck, R.K. Jaiswal, R. Douglas, J.D. Mosca, M.A. Moorman, D.W. Simonetti, S. Craig and D.R. Marshak, Multilineage potential of adult human mesenchymal stem cells, Science 284 (1999), 143-147.
16. D.J. Prockop, Marrow stromal cells as stem cells for nonhematopoietic tissues, Science 276 (1997), 71-74.
17. M. Reyes, T. Lund, T. Lenvik, D. Aguiar, L. Koodie and C.M. Verfaillie, Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells, Blood 98 (2001), 2615-2625.
18. W.T. Tse, J.D. Pendleton, W.M. Beyer, M.C. Egalka and B.C. Guinan, Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation, Transplantation 75 (2003), 389-397.
19. S. Watikani, T. Saito and A.I. Caplan, Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine, Muscle Nerve 18 (1995), 1417-1426.
20. D. Woodbury, E.J. Schwanz, D.J. Prockop and I.B. Black, Adult rat and human bone marrow stromal cells differentiate into neurons, J. Neurosci. Res. 61 (2000), 364-370.